We are live on ! Find out more
Nicholas Company

Nicholas Company Portfolio holdings

AUM $5.47B Turnover 6.8%
1-Year Est. Return 16.96%
This Fund
S&P 500
This Quarter Est. Return
+3.67%
1 Year Est. Return
+16.96%
3 Year Est. Return
+65.72%
5 Year Est. Return
+94.16%
10 Year Est. Return
+404.17%
AUM
$4.5B
AUM Growth
+$94.9M
Cap. Flow
-$25.6M
Cap. Flow %
-0.57%
Top 10 Hldgs %
21.03%
Holding
225
New
17
Increased
85
Reduced
77
Closed
10
Avg Time Held
2.2 years
Top 10 Avg Time Held
1.6 years
Top 20 Avg Time Held
1.7 years

Top Buys

Rank Stock Value
1
FAST icon
Fastenal
FAST
+$35.3M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$21M
3
KDP icon
Keurig Dr Pepper
KDP
+$20.3M
4
EFX icon
Equifax
EFX
+$17.3M
5
EWBC icon
East-West Bancorp
EWBC
+$13.4M

Top Sells

Rank Stock Value
1
DVA icon
DaVita
DVA
+$42.1M
2
GWW icon
W.W. Grainger
GWW
+$41.1M
3
ABBV icon
AbbVie
ABBV
+$35.2M
4
SWKS icon
Skyworks Solutions
SWKS
+$25.8M
5
PNRA
Panera Bread Co
PNRA
+$11.9M

Sector Composition

Rank Sector Weight
1 Healthcare 21.03%
2 Technology 17.98%
3 Financials 15.03%
4 Industrials 14.79%
5 Consumer Discretionary 13.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
CYBR icon
151
DELISTED
CyberArk
CYBR
$5.34M 0.12%
106,835
+14,385
+16% +$726K
2016 Q3
3 quarters
MRTN icon
152
Marten Transport
MRTN
$1.05B
$5.33M 0.12%
486,263
-20,987
-4% -$210K
2013 Q2
16 quarters
XPO icon
153
XPO
XPO
$22.1B
$5.29M 0.12%
236,661
– –
2014 Q2
12 quarters
VREX icon
154
Varex Imaging
VREX
$784M
$5.21M 0.12%
154,180
+65
+0% +$2.21K
2017 Q1
1 quarter
ECOL
155
DELISTED
US Ecology, Inc.
ECOL
$5.19M 0.12%
102,740
+79,995
+352% +$3.96M
2016 Q4
2 quarters
PBH icon
156
Prestige Consumer Healthcare
PBH
$2.33B
$5.15M 0.11%
97,465
+28,055
+40% +$1.5M
2013 Q2
16 quarters
GBCI icon
157
Glacier Bancorp
GBCI
$5.7B
$5.1M 0.11%
139,210
+9,610
+7% +$329K
2013 Q2
16 quarters
GCP
158
DELISTED
GCP Applied Technologies Inc.
GCP
$5.09M 0.11%
166,795
+65
+0% +$2.04K
2017 Q1
1 quarter
DORM icon
159
Dorman Products
DORM
$3.67B
$5.08M 0.11%
61,435
-155
-0.3% -$12.7K
2016 Q1
5 quarters
ICFI icon
160
ICF International
ICFI
$1.59B
$5.07M 0.11%
107,710
– –
2016 Q2
4 quarters
SP icon
161
DELISTED
SP Plus Corporation
SP
$5M 0.11%
163,815
-535
-0.3% -$16.6K
2013 Q2
16 quarters
XLNX
162
DELISTED
Xilinx Inc
XLNX
$5M 0.11%
77,665
-40
-0.1% -$2.52K
2016 Q4
2 quarters
MORN icon
163
Morningstar
MORN
$7.85B
$4.98M 0.11%
63,580
+9,230
+17% +$697K
2013 Q2
16 quarters
WMGI
164
DELISTED
Wright Medical Group Inc
WMGI
$4.95M 0.11%
180,150
+5,390
+3% +$152K
2015 Q4
6 quarters
DLX icon
165
Deluxe
DLX
$1.05B
$4.93M 0.11%
71,240
+140
+0.2% +$9.76K
2016 Q1
5 quarters
EPAY
166
DELISTED
Bottomline Technologies Inc
EPAY
$4.91M 0.11%
191,080
+15,000
+9% +$368K
2013 Q2
16 quarters
BRO icon
167
Brown & Brown
BRO
$22.7B
$4.85M 0.11%
225,170
-1,070
-0.5% -$22.9K
2013 Q2
16 quarters
BGS icon
168
B&G Foods
BGS
$197M
$4.76M 0.11%
133,655
-75
-0.1% -$2.98K
2013 Q2
16 quarters
DSGX icon
169
Descartes Systems
DSGX
$7.58B
$4.75M 0.11%
195,275
– –
2015 Q2
8 quarters
PANW icon
170
Palo Alto Networks
PANW
$303B
$4.71M 0.1%
+211,050
New +$4.26M
2017 Q2
0 quarters
TECH icon
171
Bio-Techne
TECH
$11.4B
$4.7M 0.1%
160,060
– –
2013 Q3
15 quarters
TILE icon
172
Interface
TILE
$2.08B
$4.69M 0.1%
238,660
– –
2016 Q4
2 quarters
CORE
173
DELISTED
Core Mark Holding Co., Inc.
CORE
$4.66M 0.1%
141,100
+5,145
+4% +$175K
2016 Q1
5 quarters
EFII
174
DELISTED
Electronics for Imaging
EFII
$4.63M 0.1%
97,635
– –
2016 Q1
5 quarters
CAVM
175
DELISTED
Cavium, Inc.
CAVM
$4.61M 0.1%
74,270
-2,700
-4% -$189K
2013 Q2
16 quarters
5 6
7
8 9

Similar funds

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
EFG International
EFG International Zurich $5.46B AUM
Antipodes Partners
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Exor N.V.
Exor N.V. Amsterdam, Netherlands $5.46B AUM 6.21% 1-Year Est. Return
Abrams Capital Management
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
Voleon Capital Management
Voleon Capital Management Berkeley, California $5.49B AUM 56.94% 1-Year Est. Return
Glenview Capital Management
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
TD Private Client Wealth
TD Private Client Wealth New York $5.44B AUM 18.56% 1-Year Est. Return

Nicholas Company's Q2 2017 Portfolio in Review

As of Q2 2017, Nicholas Company held 225 positions worth $4.5B, up 2.2% from $4.4B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Nicholas Company's Q2 2017 filing shows 17 new, 85 increased, 77 reduced and 10 closed positions. Its largest new stake was Keurig Dr Pepper: 216,925 shares worth $19.8M. The largest sale was DaVita, an estimated $42.1M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 22% a quarter earlier, followed by Technology and Financials.

  • Nicholas Company's largest Q2 2017 buy was Keurig Dr Pepper: 216,925 shares worth $19.8M.
  • Nicholas Company added most to Fastenal in Q2 2017, an estimated $35.3M increase.
  • Nicholas Company's biggest Q2 2017 reduction was DaVita, cutting an estimated $42.1M.
  • Nicholas Company fully exited AbbVie in Q2 2017, selling an estimated $35.2M.
  • Nicholas Company's ten largest holdings make up 21% of its $4.5B portfolio in Q2 2017.
  • Nicholas Company opened 17 new positions and closed 10 in Q2 2017.
  • Nicholas Company's portfolio value rose 2.2% quarter-over-quarter to $4.5B.

Based on Nicholas Company's 13F filing for Q2 2017, filed 11 Aug 2017.